Latest News & Features
Refine Search
Biotechnology
Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy. 27 July 2023
article
Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand. 27 July 2023
Europe
Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector. 25 July 2023
Big Pharma
SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis. 20 July 2023
Americas
Polpharma’s injunction bid fails as motion is dismissed with prejudice | Court upholds Swiss Arbitration process. 20 July 2023
Biotechnology
Opposition Division ruling supports the use of immunotherapy patent | Highlights the significance of plausibility in patent evaluation following G 2/21. 18 July 2023
Big Pharma
Delaware court permits counterclaims from Vizgen and Nanostring in separate suits | Firms say patents-in-suit were covered by ‘open and non-exclusive licenses’. 13 July 2023
Big Pharma
Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules. 13 July 2023
Americas
Precedential decision marks blow for medical device maker after earlier win | PTAB criticised for “fundamental legal error” and “narrow definition”. 11 July 2023
Generics
Decision affects a patent listed in the Orange Book | Generic drug makers have so far failed to secure approval for biosimilar versions of the blockbuster drug. 11 July 2023